SCIslet Research Tools
Diabetes Research (Research Use Only)
Pre-clinicalActive
Key Facts
Indication
Diabetes Research (Research Use Only)
Phase
Pre-clinical
Status
Active
Company
About Salentra Biosciences
Salentra Biosciences is a private, pre-revenue biotech founded in 2018, focusing on the diabetes research tools market. The company's core asset is a proprietary platform for producing fully differentiated, functional stem cell-derived islets (SCIslets) intended for sale to academic and industrial researchers. With a founding team and advisory board rooted in stem cell and beta cell biology expertise from institutions like Washington University in St. Louis, Salentra aims to address the critical shortage of high-quality, human-relevant islet cells for research. Its business model is currently service/platform-based, providing research tools rather than developing its own therapeutics.
View full company profile